Background: Protein kinases play central roles in cell and tissue development.
Introduction
Protein kinases are key players in the regulation of cellular pathways and abnormal phosphorylation might lead to diseases. More than 500 kinases are encoded in the human genome. Due to the fact that they can easily be modulated by small increased in the presence of the pathogenic peptide amyloid-β [16, 17] . In biopsies from PD patients CK2β subunits could be found in Lewy bodies [18] .
The aim of the present study was to elucidate the role of CK2 in neurogenesis and differentiation. Neurogenesis takes place all over the life span in different neural stem cell niches in both, central and peripheral nervous system, and can be influenced by diseases, diet or inflammation. However, very little is known about the role of CK2 in stem cell differentiation. We used recently introduced small molecule CK2 inhibitors, that were applied for the treatment of cancer [19, 20, 21, 22] , to study a possible influence on still ongoing neurogenesis in the central and peripheral nervous system. Neural stem cell differentiation can be experimentally investigated by using neural stem cells, e.g. from the mouse, that were cultured as so-called neurospheres.
These cells can be obtained from highly proliferative areas within the postnatal brain, for example from the subventricular zone (SVZ) or the dentate gyrus in the hippocampus. The neurospheres contain mainly neural stem cells, but also small amounts of already differentiated neurons or glial cells, and can be differentiated using e.g. retinoic acid alone or in combination with extracellular matrix proteins, such as laminin. The differentiated cells can be characterized with marker proteins that are unique for the cell types. Typical marker proteins are βIII-tubulin and PGP9.5 for neurons, glial fibrillary acidic protein (GFAP) for astrocytes and nestin for neural stem cells. Here, we investigated the role of CK2 inhibition in neurogenesis in the central nervous system concerning proliferation and differentiation of neural stem cells derived from the subventricular zone (SVZ).
Materials and methods

Animals
Balb/c wild-type mice of both sexes aged 2-5 days were used.
Animal preparations were conducted with the general approval for the killing of animals and the removal of organs and tissues by the LUA (Landesuntersuchungsamt) Rhineland Palatinate, according to the animal protection laws in RhinelandPalatinate, Germany.
Isolation and cultivation of neural stem cells from the subventricular zone of newborn mice
For isolation of neural stem cells either 2 or 4 animals were used depending on the experiment. For protein extraction and proliferation experiments 4 animals were used. The brains of postnatal mice were removed after quick decapitation and stored in ice cold MEM-Hepes (Minimal essential medium, Gibco, with 1% penicillin/streptomycin). The subventricular zones were dissected from both hemispheres under microscopical control and transferred into 1 ml accutase solution. The digestion was performed at 37°C for 20 min. The tissue pieces were triturated using consecutively 23 and 27 gauge needles, 3 times each. To avoid shear stress, aspiration of the tissues was performed slowly. After dissociation, the cells were centrifuged (120xg, 5 min), the supernatant removed and the pellet resuspended in 1 ml proliferation medium (DMEM/F12, 1% BSA, 2% B27 supplement without retinoic acid, 1% penicillin/streptomycin, 0.1% β-mercaptoethanol, 20 ng/ml FGF, 10 ng/ml EGF). 500000 cells from the subventricular zones (SVZ cells) were seeded per T25 culture flask and cultivated at 37°C and 5% CO 2 . The media were changed every 3 days. Neurospheres appeared within 2-4 days in vitro. For the individual experiments, the neurospheres had to be cultivated for 5 days to produce sufficient cell numbers for the following experiments. The neurospheres were dissociated analog to the tissue dissociation.
Prior to seeding into 6-well chambers, the dissociated cells were counted and dead cells excluded by Trypan blue assay. 100000 living cells were seeded per well in 6-well plates and cultivated for up to 72 h to investigate the expansion rates. Due to the fact, that the CK2 inhibitors were dissolved in DMSO, the cells were cultivated either in the basal medium alone, or supplemented with DMSO, respectively, in ascending concentrations of CX-4945 (Selleckchem, Munich, Germany) in DMSO (0.1 μM, 1 μM, 5 μM, 10 μM, 15 μM, 20 μM, 25 μM) to analyse a dose dependent effect. Numbers and sizes of neurospheres in the individual cultures were evaluated after 24, 48 and 72 h. The diameters where quantified in three independent experiments, images were taken with an Olympus CKX microscope (Olympus, Hamburg, Germany) with a Moticam 2500 and Motic Images Plus software (Motic). To do so, 100 spheroids were measured for each individual experiment, after 24, 48 and 72 h using the freeware image J (National Institutes of Health, freeware).
Treatment of cells
For measuring the inhibition of CK2 activity, SVZ cells from 4 animals were cultivated for 5 days to produce neurospheres and a cell pool which was large enough for the following experiments. Cells were dissociated and 1 million cells per 5 ml were seeded. Cells were cultivated for two more days to generate small neurospheres prior to the addition of CX-4945 or quinalizarin (Labotest OHG, were cultivated for 4 to 5 days to form small neurospheres, which were dissociated and seeded in a density of 1 million cells per 5 ml in differentiation medium. After 0 h or after 72 h 10 or 20 μM CX-4945 or 40 μM quinalizarin were added. As controls DMSO (added at 0 h) or the differentiation medium were used. Five days after starting the differentiation process, cells were harvested by utilizing accutase to detach the cells from the bottom of the culture flask. After centrifugation the supernatants were discarded and the pellets stored at −80°C.
Extraction of cellular proteins
Pellets were lysed with 40-60 μl of RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% sodium desoxycholate, 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS) supplemented with the protease inhibitor cocktail Complete TM according to the manufacturer's instructions (Roche Diagnostics, Mannheim, Germany)). The cell lysate was left on ice for 30 min, before being subjected to sonification (3 × 30 s) at 4°C. Then the cell debris was removed by centrifugation at 16100xg at 4°C for 30 min. The protein content of the supernatant was determined according to the Bradford method using the Bio-Rad protein assay reagent (Bio-Rad, Munich, Germany).
Protein kinase CK2 assay
To study the CK2 kinase activity in vitro, 30 μg of total protein were mixed with kinase buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM 
FACS analysis
To investigate the influence of CX-4945 on the cell cycle the progenitor cells were cultured for 5 days to generate sufficient amounts of cells. Initially, they were dissociated as described and seeded at a density of 1 million cells per 5 ml medium.
Cells were treated with 10 or 20 μM CX-4945 for 24 h in proliferation medium. As controls, DMSO and the usual proliferation medium were used. After 24 h, the cells were harvested for cell cycle analysis. Cells were centrifuged at 120xg for 5 min and dissociated carefully with accutase to avoid clustering during the cell cycle analysis.
Cells were centrifuged, the supernatant was discarded and 2 ml cold 70% ethanol per 1 million cells were added with gentle vortexing. Cells were stored for 2 h at 4°C.
Subsequently, the samples were centrifuged at 300xg for 1 min to remove the ethanol. To wash the cells 1 ml PBS was added and cells centrifuged again as described before.
After this washing procedure, cells were stained with FxCycle PI/RNase staining (Life technologies) solution and incubated for 15 to 30 min at room temperature. 
Induced differentiation
Statistics
The statistical analysis of the proliferation measurements was performed utilizing the Kruskal Wallis test, a non-parametric test, by applying MedCalc 12 software (MedCalc Software bvba, Ostend, Belgium). The significances were set as * p-value ≤ 0.05, ** p-value ≤ 0.01 and ***p-value ≤ 0.001.
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To assess the significant differences in the individual, we used a non-parametric Mann-Whitney test by comparing the groups with the DMSO control by applying the statistical software SigmaPlot 13.0. The significances were set: * p-value ≤ 0.05, ** p-value ≤ 0.01 and ***p-value ≤ 0.001.
Results
Protein kinase CK2 plays a central role for the regulation of eukaryotic cell proliferation. Inhibition of the kinase activity of CK2 leads to severe disturbances of cell proliferation and the induction of apoptosis in nearly all tumour cells. So far only little is known about a role of CK2 in stem cell proliferation and differentiation. Here, we investigated the impact of CK2 inhibition on neural stem cells, derived from the early postnatal mouse brain. Over the last 10 years a great number of different inhibitors of the kinase activity of CK2 have been described [7, 23] . Among these inhibitors, CX-4945 is the most interesting one being already tested on 235 kinases and found to be specific for CK2 [24] . Due to its specificity and bioavailability CX-4945 is now used in clinical trials [20] . To assure that the observed effects are in fact due to a reduction in the CK2 kinase activity we used a second well-established CK2 inhibitor, namely quinalizarin [25] .
Quinalizarin was tested on 72 kinases and found to be specific for CK2 as well [25, 26] . Different concentrations were tested (data not shown) and the most suitable one, which was a compromise between apoptosis induction and CK2 inhibition, namely For the analysis of a statistical significance a non-parametric Kruskal-Wallis test was applied. Lower limit of measured neurosphere sizes was ≤20 μm. Scale bar 500 μm.
are appropriate to inhibit CK2 activity, proliferating SVZ were left untreated or treated with the given concentrations of the inhibitors for 24 h. Cells were harvested and either subjected to an in vitro phosphorylation assay with the CK2 specific substrate peptide RRRDDDSDDD [27] or a Western blot analysis. Fig. 2A demonstrates that both CK2 inhibitors reduced the CK2 activity, albeit to a different degree. At lower concentrations CX-4945 was more potent than quinalizarin. CX-4945 reduced the CK2 activity to 31% residual activity at 10 μM and to 18% at 20 μM, whereas 40 μM quinalizarin reduced the activity only to 61%. The Western blot analysis with antibodies recognizing the different subunits of CK2 (Fig. 2B) shows that the expression of these proteins is not influenced by the inhibition.
A reduction in the size of the neurospheres as well as the reduction in the number of cells in neurospheres might be induced by cell cycle arrest or the induction of phase, similar to the DMSO control, indicating that there is almost no apoptosis.
To investigate the role of CK2 inhibition on neuronal and glial differentiation, the neural stem cells were selectively differentiated for five days by using retinoic acid and extracellular matrix coatings. Neurons were detected by staining the cells with an antibody against βIII-tubulin and astrocytes were identified by staining with an antibody against glial fibrillary acidic protein (GFAP). Neural stem cells were stained with an antibody against the neuroepithelial stem cell protein (Nestin).
Nestin is a general marker for neural stem cells and gives a first impression of neural stem cell concentrations. It is phosphorylated at Thr316 by cdc2 during mitosis to enable remodelling of the cytoskeleton [28] . The use of antibodies for both phosphorylated and non-phosphorylated nestin allows to identify nestinpositive cells that are in the mitotic circle, and thus most probably expressing a neuronal stem cell character. Due to the fact, that nestin can also be expressed in regenerating neurons and glial cells, the unphosphorylated nestin gives rather an impression of ongoing regeneration seen in tissue culture. Article No~e00318 cells (red) (Fig. 4B) . The nestin staining in Fig. 4C and D shows that the total nestin (green) signal was stronger in the undifferentiated neurospheres compared to the differentiated ones, indicating down-regulation during differentiation. In the differentiated cultures also no phosho-nestin (red, indicating mitotic cells) could be detected. Next, we analysed the expression of glial, neuronal and stem cell markers between day 0 (undifferentiated) and day 21 of differentiation ( Fig. 4E) . We could clearly see that neuronal and glial markers increased with differentiation, whereas nestin expression was strongest in the undifferentiated stage. Interestingly, Article No~e00318 βIII-tubulin expression was transient with a maximum at day 5 of differentiation.
Due to this transient expression we used the pan-neuronal protein Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1 or PGP9.5) as a second neuronal marker. The expression of PGP9.5 increased steadily until day 14 and was slightly reduced at day 21, probably due to beginning neuronal die-off often observed in long time cultures. To assay a possible role for CK2 we then analysed the expression of the individual subunits during the differentiation process. As shown in Fig. 4F there was a decrease in the amount of CK2α and CK2α' with the progress of differentiation. The decrease of CKβ started at later time points of differentiation. The analysis of the CK2 kinase activity is shown in Fig. 4G . CK2
kinase activity remained nearly the same until day 5 and decreased thereafter.
Thus, we have shown that in the presence of retinoic acid, SVZ cells differentiate from neural stem cells to glial and neuronal cells and that this differentiation goes along with a decrease in the level of the CK2 subunits and CK2 kinase activity.
In a next step we analysed the differentiation of the SVZ in the presence or absence of a CK2 inhibitor. We treated the cells either with the solvent DMSO as a control or with 10 or 20 μM CX-4945 or with 40 μM quinalizarin. The CK2 inhibitor was added either immediately at the beginning of the differentiation process (0 h) or at 72 h after induction of differentiation. In pilot experiments (data not shown) we saw, that the effects of the inhibitors decreased, the later they were added to the differentiating cultures. At 72 h this effect was, if ever, very small. We therefore used 72 h as the second time point. Independently of the time point when the inhibitor was added, immunofluorescence was always performed five days after start of differentiation ( Fig. 5B-I ) and βIII-tubulin positive neurons (green) or GFAP positive astrocytes (red) were counted and presented in bar graphs (Fig. 5A ). In the control cultures (DMSO or normal medium) we found 40% βIII-tubulin-positive neurons (green) and 50% GFAP-positive astrocytes (red) after 5 days under differentiation conditions (Fig. 5A-C) . Both neurons and glial cells showed a normal morphology with extended neurites in neurons (green) and starlike processes in astrocytes (red). Inhibiting the CK2 activity with CX-4945 or quinalizarin resulted at least in part in a failure of differentiation.
Inhibition of CK2 kinase activity with 10 μM CX-4945 from the beginning of differentiation reduced the signal of GFAP staining (Fig. 5D ) indicating reduced glial differentiation, whereas neuronal differentiation was not affected. When CK2
was inhibited with the same concentration 72 h after start of differentiation (Fig. 5E ), the numbers for both cell types were comparable to those in control cultures. The inhibition of CK2 with 20 μM CX-4945 from the start of differentiation resulted in no detectable differentiation of neurons (lack of green βIII-tubulin staining (Fig. 5F ). The overall cell number was reduced, probably due to apoptosis, but the majority of the remaining cells showed a GFAP-staining,
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although the intensity of the expression was very low, and the cells were very small with short processes (Fig. 5G, red staining) . When CK2 was inhibited from 72 h after start of differentiation, the glial population did not change much in relative numbers of glial cells to neurons. The amount (Fig. 5A ) and quality ( Fig. 5G ) of neurons increased, but it did not reach the control samples. Although there was a beginning of neurite outgrowth, the neurites exhibited pathological swellings (Fig. 5G) . Cultures that where inhibited with 40 μM quinalizarin from the beginning of differentiation showed a reduced outgrowth of the neurospheres and slight apoptosis, but not as strong as seen with 20 μM CX-4945. The number of neurons was reduced significantly, but the neurons had a normal morphology (Fig. 5H) . Glial cell differentiation was not affected. When the CK2 kinase activity was inhibited with quinalizarin 72 h after start of differentiation cell numbers and morphologies of both cell types were comparable to control cultures (Fig. 5I) .
In order to confirm the experiments obtained by immunofluorescence we repeated the experiments but in this case, proteins were extracted from differentiated cells and analysed by Western blotting. Cells were treated with CX-4945 (10 or 20 μM)
either at the start of the differentiation or 72 h after the start of the differentiation. In order to demonstrate CK2 inhibition during differentiation, we first measured CK2 kinase activity in cell extracts. As shown in Fig. 6A , in differentiated cultures 10 μM CX-4945 reduced the CK2 activity to 61% (0 h) and 49% (72 h) residual activity and 20 μM reduced it to 19% (0 h) and 25% (72 h). In a next step, we subjected the extracts to SDS-polyacrylamide gel electrophoresis followed by Western Blot analysis where we compared GFAP and βIII-tubulin marker protein expression in the absence (DMSO) or presence of the inhibitor. As shown in 
A very similar observation was made for the βIII-tubulin expression after treatment with 20 μM CX-4945 indicating that CK2 inhibition at the beginning of differentiation blocked neural differentiation completely, while CK2 inhibition after 72 h of differentiation resulted in a reduced but detectable neuronal differentiation compared to the control. In contrast, the inhibition of CK2 activity using 10 μM CX-4945 had no effect at all on neuronal differentiation i.e. protein bands for βIII-tubulin showed the same intensity as the DMSO control, whether the inhibitor was added at the beginning or after 72 h of differentiation. These results confirm the observation of the immunofluorescence studies (Fig. 5) . As a general conclusion of these data, we can say that CK2 inhibitors have a very strong toxic effect on neural stem cells, and can inhibit, even at non-toxic concentrations, the glial differentiation.
As the induction of apoptosis might also play a role during differentiation we performed an in situ TUNEL assay. The TUNEL reaction preferentially labels DNA strand breaks generated during apoptosis. SVZ cells were induced to differentiate and either treated with 10 μM CX-4945, 20 μM CX-4945 or with 40 μM quinalizarin either immediately (0 h) or 72 h after the start of differentiation. Five days after the start of differentiation cells were subjected to a TUNEL assay ( Fig. 7A-H) . TUNEL positive cells (green) were counted, the counts were normalised to the DMSO control and presented as bar graphs. As demonstrated in Fig. 7 treatment of SVZ with 10 μM CX-4945 either at 0 h or at 72 h showed no indication for apoptosis (Fig. 7A-D) , while a concentration of 20 μM CX-4945 led to an elevated level of apoptosis (E and F). Treatment of SVZ with quinalizarin however resulted at least in part in the induction of apoptosis when applied at 0 h, but it had no effect when added at 72 h after start of differentiation.
We also investigated the immediate impact of CK2 inhibition on neural stem cell numbers and properties, based on nestin staining. DMSO alone did not alter the number of nestin-positive cells compared to the basic culture medium. Fig. 8 shows astrocytes, the nestin-positive cells were very small and hard to discriminate (Fig. 8F) . Even when the compound was added at 72 h, the morphology of the nestin positive cells was different compared to the control (Fig. 8G) . Quinalizarin led to a similar result when added at 0 h, while a late addition of the inhibitor had no effect at all (Fig. 8H-I ). The non-toxic concentration of CX-4945 (10 μM) did not influence nestin positive cell numbers significantly ( Fig. 8D and E) .
In order to investigate whether the influence of CK2 inhibition by CX-4945 decreases or even disappears with time of differentiation, we expanded the differentiation period up to three weeks and investigated whether there were differences between inhibitor treated and control cultures. We decided to treat the SVZ with the highest concentration of CX-4945 because it exerted the strongest effects on differentiation under these conditions. Here, the cultures were differentiated for 14 and 21 days (data only shown for 14 days), and then 20 μM CX-4945 was added to the differentiation medium for another three days. For both time points, the addition of the inhibitor did not lead to any significant changes (Fig. 9) . The cultures showed similar properties and glia to neuron-ratios (Fig. 9A) . The expression patterns of astrocytic (GFAP, red) and neuronal (βIII-tubulin, green) cells is shown for the differentiation medium alone (Fig. 9B) , for DMSO supplemented differentiation medium (Fig. 9C) , or differentiation medium with CX-4945 (Fig. 9D) . Similar findings were observed for the expression of nestin and the number of nestin-positive cells (Fig. 9E-H) .
The experiment demonstrates that CK2 does neither have an impact on neural and glial differentiation nor on the remaining stem cell population at later time points during differentiation. Overall, we conclude that CK2 inhibitors have a crucial influence upon neural stem cell survival, when used in concentrations from 20 μM (CX-4945) or 40 μM (quinalizarin) onwards. This effect leads to significantly reduced neuronal and glial cell numbers. Moreover, the CK2 inhibition of CX-4945 in a non-toxic (10 μM) concentration leads to a decrease in glial differentiation.
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Discussion
In the present study, we have shown for the first time that CK2 has a strong impact on the proliferation and differentiation of neural stem cells from the subventricular zone. Inhibition of the enzyme leads to a significant reduction of the proliferative capacity. During differentiation, the inhibition of CK2 interrupts the neural and glial lineages within a time window of around three days. At later stages of Article No~e00318 differentiation CK2 kinase activity seems to be dispensable. Although it was demonstrated that CK2 is involved in the development of the nervous system [15] , information concerning the involvement of kinase-dependent pathways in neurogenesis is rare. This might mainly be due to the severe and lethal neurodevelopmental phenotypes of CK2α or CK2β knockout mice [15, 29, 30] .
The study by Huillard demonstrated that the interruption of the CK2β subunit expression caused a negative regulation of oligodendrogenesis. CK2β obviously interacts with the bHLH transcription factor Olig2, which is one of the key regulators for oligodendrocyte development [15] .
Ziercher et al. have demonstrated that embryonic stem cells without CK2β exhibited a defect in viability. They have further shown that CK2β is necessary for oligodendroglia differentiation of neurospheres [31] . Obviously, the influence of CK2β is due to a defect in the CK2 kinase activity of the holoenzyme in the absence of CK2β. Without CK2β, those substrates that are phosphorylated only by the holoenzyme will not be phosphorylated. Jauch et al. have shown a role of Drosophila CK2β for cell proliferation or cell survival during brain development [32] . One of the possible substrates is the nucleolar mushroom body miniature (mbm) protein. This protein is implicated in nutrient dependent signalling pathways controlling ribosomal expression [33] . The idea that the holoenzyme is the functional form of CK2 implicated in the proliferation and differentiation of neurosphres is strongly supported by our present results with inhibitors of the kinase activity of CK2.
Moreover, the genetic interruption of embryonic neurogenesis leads to a reduced proliferation and self-renewal of the neural stem cells. These findings are quite consistent with our data from inhibited postnatal neural stem cells derived from the subventricular zone. Using knock-down approaches or CK2 inhibitors can overcome the lethality problem and does allow to investigate the postnatal role of CK2 in the nervous system. Using these approaches the role of CK2 in the nervous system could be evaluated further. Thus, it turned out that CK2 is obviously involved in ion channel organization [34, 35] and synaptic transmission [36, 37] .
CX-4945 is a potent inhibitor of the kinase activity of CK2 [38] , which was introduced as an anti-cancer drug [20] . So far it could be demonstrated that CX-4945 provides cytotoxic activities in acute lymphoblastic leukemia cells [21] , attenuates prosurvival signalling in human breast cancer cells [19] or might be used for the treatment of cancer stem cells in glioblastomas [22] . Moreover, CX-4945 seems to regulate osteoblast differentiation in vitro [39] and might serve as a splicing regulator [40] . In a recent study it was shown that CX-4945 treated human mesenchymal stem cells differentiate into adipocytes similar to untreated cells [41] . It turned out that the failure in inhibiting differentiation was accompanied by showing that this concentration is non-toxic. In this case we detected an inhibition of gliogenesis but not of neurogenesis supporting the observation that neuronal precursors are more sensitive to apoptosis at higher inhibitor concentrations. Using quinalizarin in different concentrations we obtained either strong apoptosis or no inhibition of the CK2 kinase activity. 40 μM quinalizarin resulted in an inhibition of the CK2 kinase activity by around 40%. In this case we observed an inhibition of neurogenesis but not gliogenesis. From the results obtained with the two inhibitors one might speculate that the inhibition of neurogenesis is somehow connected with apoptosis induction and the inhibition of gliogenesis is directly connected to CK2 inhibition. This speculation is supported by the observation by Huillard and Ziercher who had demonstrated that the interruption of the CK2β subunit expression causes a negative regulation of oligodendrogenesis [15, 31] .
The time point when CK2 kinase activity is required for differentiation seems to be crucial. While knock-out of CK2β in embryonic stem cells leads to an overall developmental breakdown [29] , a timely activation or inhibition of the enzyme within a specific organ system might be important for the lineage finding, especially when the enzyme is partially up-or down-regulated. Our data have
shown that, during a period of 1-3 days, the inhibition of CK2 abrogates differentiation of stem cells.
A very important aspect in the role of CK2 in neurogenesis is also the interdependencies of the individual partners, such as neurons and glial cells. It is well known that glial cells provide a broad range of trophic factors and cytokines that can positively influence the survival and differentiation of neurons [42] .
The present findings in the nervous system are in line with results obtained with CX-4945 in osteoclast differentiation. Moreover, it was shown that CX-4945
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inhibited the RANKL induced osteoblast differentiation. In contrast to this finding CX-4945 enhanced the BMP2 induced osteoblast differentiation [39] . In another study, which analysed the differentiation of preadipocytes into adipocyctes it was
shown that the CK2 kinase activity increased at the beginning of the differentiation process and decreased with ongoing differentiation. Moreover, inhibition of the CK2 kinase activity at the beginning of the differentiation for up to 6 days after start of differentiation prevents differentiation whereas after day 6 there was no inhibition of differentiation anymore [43] . Thus, these results are in a good agreement with the data presented here for neural differentiation.
Future studies with graded up-and down-regulations of CK2 will show whether CK2 will also be involved in fate decision of neurons and glial cells during differentiation.
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